Oncolytics Biotech Inc ONCY

Could the volume here get any lower???????

[Hcallahan44]

how is it possible there is a big announcement looming...when there are ten shares trading

[inthno]

I have resigned myself to the idea that it is not a big announcement. It is only 1 of many abstracts that are being presented by companies and even though we had amazing results with the first 3 patients it is stil an abstract and generally from my experience that does not trigger a sp increase or decrease until the release of the abstract and results. Will it be on just the first 3 paitients or

[Hcallahan44]

thanks,,,its good to find another voice of reason here amidst the endless pumping and 8 billion dollar buy out promises   i dont think the share price will move at all next week....it might go down....good new never stays a secret in the markey

[Lesalpes29]

Hope that next week results will open the gates for patnership or real discussions for a buyout if not already on. GL

[lonc17]

I think this last hour of trading on Friday will be a sign of what to expect on Monday morning.  If there is no uptick then I'm guessing we'll hear no more than "the first three patients responded well" which would be characteristic of the endless wait we all face but disappointing. Perhaps an bump up of 5 or 10 cents in this next hour might be reason for optimism.

[Buckhenry]

too many here I have been wishing and hoping and may be setting themselves up for a big letdown next week. oncy management will decide the course on their terms. all we can hope for is good data and not get caught up in the stock price at buyout otherwise im afraid your next week will be quite disappointing. I think the timeframe for something good could be in the next six months if data and

[jimsenior]

I was looking at GOBLET from my lay perspective; that is to say with very little understanding of trials. Any of the four cohorts showing an ORR (overall response rate) above a prespecified threshold in Stage 1 (defined as achieving a minimum number of radiologic responses by week 16) may be advanced to Stage 2 and enroll additional patients. We know there are 27 out of 55 enrolled. Can we infer

[Proboscises]

The GOBLET trial is for four different types of gastro-intestinal cancer, including pancreatic cancer. The trial design envisions a total of 55 total patients for all four GI cancers, of which 12 were supposed to be for pancreatic cancer. We don't know how many patients have so far been enrolled in the pancreatic arm or when they were enrolled.  The GOBLET trial was expected to run from

[Pelaimmune]

Remember you from old ONCY V2 board.  Glad to see you are still around. 

[Proboscises]

Yes, I'm still around and still invested in ONC. Let's see what happens during the month of November. I'll be listening intently Monday morning.